Publications

Digital Learning in Transplantation

Digital Learning in Transplantation. Riella LV. Transplantation. 2016 Apr;100(4):701-702. PMID: 26998849 Physicians are lifetime learners in a world of rapidly changing information. Understanding the science of learning well and using the best available tools…

Leonardo Riella03/2016

Book Chapters Publications

Transplant-Related Complications

Riella LV, Chandraker A. “Transplant-related Complications,” In: Li and Jevnikar. "AST Handbook of Transplant Immunology". 1st Edition, Wiley Blackwell 2015

Leonardo Riella03/2016

Book Chapters Publications

Global Considerations of Kidney Disease – Latin America

Riella LV, Riella MC. “Global Considerations of Kidney Disease – Latin America,” In: Brenner & Rector’s “The Kidney”. 9ht Edition, Saunders 2015; Chapter 77, Pages 2440-2452.

Leonardo Riella03/2016

Book Chapters Publications

Transplantation Immunobiology

Chandraker A, Riella LV, Sayegh MH. “Transplantation Immunobiology,” In: Brenner & Rector’s “The Kidney”. 9ht Edition, ; Saunders 2015; Chapter 71, Pages 2228-2250

Leonardo Riella03/2016

Blog Immune regulation

NephMadness 2016: The Promising Future of Tregs in Transplantation

The immune system has to be tightly regulated to avoid collateral damage. The discovery of regulatory cells in 1985 yielded one of the most important immunological advances in the past…

Leonardo Riella03/2016

Publications Research Articles

Co-Dominant Role of IFN-γ- and IL-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.

Facial transplantation is a life-changing procedure for patients with severe composite facial defects. However, skin is the most immunogenic of all transplants and better understanding of the immunological processes after…

Leonardo Riella01/2016

Publications Reviews

Notch and its ligands in alloimmunity and rejection.

The Notch signaling pathway is known to play a pivotal role in T- and B-cell development and fate, presenting it as an attractive therapeutic target in alloimmunity. This review provides…

Leonardo Riella01/2016

Editorials/Perspectives Publications

CD4+ CD28 Negative Cells: Armed and Dangerous.

CD28 is a well-characterized co-stimulatory molecule that interacts with CD80/86 on antigen-presenting cells (APCs), comprising the critical signal 2 of T cell activation. Targeting CD28 has become an important immunosuppressive…

Leonardo Riella01/2016

Blog Rejection

Alemtuzumab for refractory rejection: what is the data?

For severe or refractory rejections, thymoglobulin/ATG is commonly employed in combination with steroids and B-cell targeted therapies when indicated. However, alemtuzumab could be more effective then thymoglobulin since it depletes…

Leonardo Riella09/2015

Filters

Year Published

Contact Us